STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 63 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $18,099,000 | -54.2% | 3,739,336 | +0.6% | 0.00% | -50.0% |
| Q4 2019 | $39,497,000 | +8.8% | 3,715,648 | +6.6% | 0.00% | 0.0% |
| Q3 2019 | $36,293,000 | -24.9% | 3,486,413 | +10.6% | 0.00% | 0.0% |
| Q2 2019 | $48,301,000 | +39.0% | 3,152,812 | +16.6% | 0.00% | 0.0% |
| Q1 2019 | $34,740,000 | +77.1% | 2,703,489 | +30.9% | 0.00% | +100.0% |
| Q4 2018 | $19,618,000 | -40.0% | 2,065,239 | +4.9% | 0.00% | 0.0% |
| Q3 2018 | $32,694,000 | +9.9% | 1,969,492 | +6.3% | 0.00% | 0.0% |
| Q2 2018 | $29,739,000 | +23.7% | 1,852,820 | +17.9% | 0.00% | 0.0% |
| Q1 2018 | $24,043,000 | +9.6% | 1,571,426 | +11.8% | 0.00% | 0.0% |
| Q4 2017 | $21,936,000 | +49.3% | 1,406,181 | +6.3% | 0.00% | 0.0% |
| Q3 2017 | $14,688,000 | +21.1% | 1,323,137 | +0.4% | 0.00% | 0.0% |
| Q2 2017 | $12,124,000 | +16.7% | 1,317,926 | +8.5% | 0.00% | 0.0% |
| Q1 2017 | $10,387,000 | +27234.2% | 1,214,893 | +33797.7% | 0.00% | – |
| Q4 2016 | $38,000 | -9.5% | 3,584 | -8.8% | 0.00% | – |
| Q3 2016 | $42,000 | +61.5% | 3,930 | 0.0% | 0.00% | – |
| Q2 2016 | $26,000 | +766.7% | 3,930 | +641.5% | 0.00% | – |
| Q1 2016 | $3,000 | +50.0% | 530 | +64.6% | 0.00% | – |
| Q4 2015 | $2,000 | -33.3% | 322 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | -25.0% | 322 | 0.0% | 0.00% | – |
| Q2 2015 | $4,000 | -33.3% | 322 | -22.0% | 0.00% | – |
| Q1 2015 | $6,000 | -14.3% | 413 | +21.5% | 0.00% | – |
| Q1 2014 | $7,000 | +40.0% | 340 | +28.8% | 0.00% | – |
| Q4 2013 | $5,000 | -58.3% | 264 | 0.0% | 0.00% | – |
| Q3 2013 | $12,000 | +100.0% | 264 | 0.0% | 0.00% | – |
| Q2 2013 | $6,000 | – | 264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|